Inozyme Pharma IPO

Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.

Register for Details

For more details on financing and valuation for Inozyme Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Inozyme Pharma's ticker symbol?


What is Inozyme Pharma's stock price?

3.04 as of 3/21/23

Learn more about Inozyme Pharma

Forge green plus iconForge green minus icon

What is Inozyme Pharma funding to date?

Inozyme Pharma has raised $115.85MM.
Forge green plus iconForge green minus icon

When was Inozyme Pharma founded?

Inozyme Pharma was founded in 2016.